Treg stability in viral infection and autoimmunity
Treg stability in viral infection and autoimmunity
批准号:
8495227
负责人:
Matthias G. Von Herrath
金额:
$43.73万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2015-06-30
关键词:
AcuteAffectAsthmaAutoimmune DiseasesAutoimmunityChronicCollaborationsDNA MethylationDataDiseaseEnhancersGenomeHeat shock proteinsHumanImmune systemInfectionInflammationInflammatoryInflammatory Response PathwayInsulin-Dependent Diabetes MellitusInterferonsInterleukin-10LigandsLymphocytic choriomeningitis virusMaintenanceMethylationMusNatureOutcomePatternPlayPopulationProductionPublishingRegulatory T-LymphocyteReporter GenesRoleTLR2 geneTestingVirusVirus Diseasescytokineepigenetic markerin vitro activityin vivopromoterresponse
中文摘要
我们的假设是,病毒感染对不同的Treg群体具有强烈和不同的影响。我们
初步数据表明,Foxp 3 + T细胞(适应性或天然存在的)和IL-10+ T细胞受到影响,
病毒感染。潜在的机制被认为与APC的调节有关,
特别是干扰素和TLR,导致对Treg激活、稳定性的强烈影响,这可能是
反映在Foxp 3启动子DNA甲基化状态的变化,以及细胞因子的产生,
基因组中表观遗传标记的整体模式的变化。明确定义基础
机制及其精确的效果不仅可以让我们更好地了解免疫系统的反应,
系统的病毒感染,但设计更好的策略,以诱导THBE治疗慢性
炎症性疾病如IBD、T1 D和哮喘。
目的1:急性或慢性病毒感染是否会使Foxp 3和/或IL-10表达和Treg活性在体外不稳定
还是在体内使用Foxp 3和IL-10基因报告小鼠,我们将检验我们的假设,即Foxp 3表达和IL-10基因的表达,
IL-10的产生在病毒感染过程中受到调节,这取决于是否
感染是急性的(LCMV Armstrong)或慢性的(LCMV克隆13)。我们将比较
在病毒感染之前、期间和之后进行治疗。
目的2:THBE如何影响病毒感染、自身免疫和哮喘的结局?在这里我们将测试
我们的假设是,不同类型的Treg,尽管它们的功效,在结果方面是不可比的,
并在体内特定疾病情况下发挥作用。
目的3:病毒感染如何影响THBE的稳定性和功能机制?初步数据显示
Treg功能是通过APC而不是病毒感染对Treg的直接影响来影响的。此外
TLR 2似乎调节并最终扩增和激活Foxp 3 + TcR。我们建议玩家在
先天性免疫系统,如DC和TLR,沿着内源性配体,如热休克
热休克蛋白(HSPs)在决定结果中起着重要作用。
英文摘要
Our hypothesis is that viral infections have strong and diverging effects on different Treg populations. Our
preliminary data indicate that Foxp3+ Tregs (adaptive or naturally occurring) and IL-10+ Tregs are affected
by viral infections. The underlying mechanisms are proposed to be related to the modulation of APCs, in
particular interferons and TLRs, resulting in strong effects on Treg activation, stability, which could be
reflected in changes in the DNA methylation status ofthe Foxp3 promoter, and cytokine production, reflected
in changes in the overall pattern of epigenetic markers in the genome. Clearly defining the underlying
mechanisms and their precise effects will allow us not only to better understand the response of the immune
system to viral infections, but to devise better strategies to induce Tregs for the treatment of chronic
inflammatory disorders such as IBD, T1D and asthma.
Aim 1: Do acute or chronic viral infections destabilize Foxp3 and/or IL-10 expression and Treg activity in vitro
or in vivo? Using Foxp3 and IL-10 gene reporter mice, we will test our hypothesis that Foxp3 expression and
IL-10 production are modulated during viral infection, and that this occurs differentially depending on whether
the infection is acute (LCMV Armstrong) or chronic (LCMV Clone 13). We will compare effector functions of
Tregs before, during, and after viral infections.
Aim 2: How do Tregs influence the outcome of viral infections, autoimmunity, and asthma? Here we will test
our hypothesis that different Treg types, in spite of their efficacy, are not comparable in terms of outcome
and function in particular disease situations in vivo.
Aim 3: How do viral infections affect Tregs stability and function mechanistically? Preliminary data indicate
that Treg function is affected via APCs rather than a direct influence of viral infections on Tregs. In addition
TLR2 appears to modulate and eventually expand and invigorate Foxp3+ Tregs. We propose that players in
the innate immune system,such as DCs and TLRs, along with endogenous ligands, such as heat shock
proteins (HSPs), play an important role in determining the outcome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treg stability in viral infection and autoimmunity
-
批准号:8377922
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2012
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8655830
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8261913
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8195256
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
-
批准号:9238399
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8451478
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity of CD8 cells in islets from type 1 diabetes patients
-
批准号:8828063
-
项目类别:
-
资助金额:$40.14万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes
-
批准号:10061526
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2011
-
负责人:Matthias G. Von Herrath
-
依托单位:
Treg stability in viral infection and autoimmunity
-
批准号:8006796
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2010
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7919813
-
项目类别:
-
资助金额:$20.7万
-
财政年份:2009
-
负责人:Matthias G. Von Herrath
-
依托单位:
Viruses and Autoimmunity POI
-
批准号:7923514
-
项目类别:
-
资助金额:$45.7万
-
财政年份:2009
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7667337
-
项目类别:
-
资助金额:$41.72万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7487519
-
项目类别:
-
资助金额:$41.72万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7313053
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
How IL-10R blockade can resolve persistent viral infections
-
批准号:7914240
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2007
-
负责人:Matthias G. Von Herrath
-
依托单位:
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
-
批准号:7469963
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
Assessment of cytokines in human islets from patients with diabetes
-
批准号:8501368
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
-
批准号:7289765
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
Assessment of cytokines in human islets from patients with diabetes
-
批准号:8373378
-
项目类别:
-
资助金额:$44.77万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
Achieving Therapeutic Antigent-Specific Tolerance in Type 1 Diabetes
-
批准号:7248524
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2006
-
负责人:Matthias G. Von Herrath
-
依托单位:
海外基金